News

Filter

Current filters:

Gambro

Baxter to expand renal therapies range with $4 billion buy of Gambro

04-12-2012

Confirming recent rumors and speculation, Baxter International (NYSE:BAX ) said yesterday it has entered…

Baxter InternationalGambroMergers & AcquisitionsNephrology and HepatologyPharmaceutical

COMPANY SPOTLIGHT

Menarini

Back to top